The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

The Effects of Gokgisaeng on Anti-inflammation and Rat C6 Glioma Cell Migration

곡기생(槲寄生)의 항염증 효능 및 암세포 이주저해에 미치는 영향

  • Kim, Hyun-Young (Dept. of Internal Medicine, College of Oriental Medicine, Dae-gu Haany University) ;
  • Jang, Soo-Young (Dept. of Internal Medicine, College of Oriental Medicine, Dae-gu Haany University) ;
  • Jeong, Ji-Cheon (Dept. of Internal Medicine, College of Oriental Medicine, Dong-Guk University) ;
  • Shin, Hyeon-Cheol (Dept. of Internal Medicine, College of Oriental Medicine, Dae-gu Haany University)
  • 김현영 (대구한의대학교 한의과대학 내과학교실) ;
  • 장수영 (대구한의대학교 한의과대학 내과학교실) ;
  • 정지천 (동국대학교 한의과대학 내과학교실) ;
  • 신현철 (대구한의대학교 한의과대학 내과학교실)
  • Published : 2013.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Gokgisaeng (Korean mistletoe) is used for the treatment of inflammatory and cancer diseases in traditional Korean medicine and its major component lectins have been reported to induce nitric oxide (NO) in RAW 264.7 macrophages, and also induce apoptosis of various types of cancer cells, although its modulatory effects on cancer cell migration and macrophage activation is poorly understood. The aim of this study is to clarify molecular mechanisms of action responsible for the anti-inflammatory and antitumor migration potentials of Korean mistletoe extract (KME). Methods : We investigated the anti-inflammatory activity of KME on NO production and inducible nitric oxide synthase (iNOS) expression by lipopolysaccharide (LPS) in both RAW 264.7 macrophages and rat C6 glioma cells, and also evaluated inhibitory efficacy on glioma cell growth and migration. For assessment, XTT assay, nitrite assay, RT-PCR, scratch-wound and Boyden chamber assay, and western blot analysis were performed. Results : Previously reported, unlike the efficacy of Gokgisaeng lectin, KME inhibited NO production and iNOS expression, and suppressed pro-inflammatory mediators including IL-$1{\beta}$, IL-6, COX-2, iNOS in LPS-stimulated RAW 264.7 cells. Furthermore, KME suppressed tumor cell growth and migration, and it also inhibited LPS-induced NO release and iNOS activation by down-regulating expression of protein kinase C (PKC) and phosphorylation of ERK in C6 glioma cells. Conclusions : Our research findings provide evidence that KME can play a significant role in blocking pro-inflammatory reaction and malignant progression of tumors through the suppression of NO/iNOS by down-regulating of inflammatory signaling pathways, PKC/ERK.

Keywords

References

  1. Aoki H, Kakinuma K, Morita K, Kato M, Uzuka T, Igor G, et al. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model. Int J Hyperthermia 2004;20(6):595-605. https://doi.org/10.1080/02656730410001703186
  2. An YL, Nie F, Wang ZY, Zhang DS. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells. Int J Nanomedicine 2011;6:3187-94.
  3. Amberger VR, Hensel T, Ogata N, Schwab ME. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 1998;58(1):149-58.
  4. Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A. Angiogenesis and invasion in gliomas. Cancer Treat Res 2004;117:263-84. https://doi.org/10.1007/978-1-4419-8871-3_16
  5. Yoo CH, Lee U, Kim YB, Kang DS, Park CW, Yoo YM. Effect of tamoxifen in C6 glioma cells. J Korean Neurosurg Soc 1997;26:5-10.
  6. Agudelo-Garcia PA, De Jesus JK, Williams SP, Nowicki MO, Chiocca EA, Liyanarachchi S, et al. Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling. Neoplasia 2011;13(9):831-40.
  7. Lamszus K, Kunkel P, Westphal M. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 2003;88:169-77.
  8. Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 1999;98(3):240-4. https://doi.org/10.1007/s004010051075
  9. Kato S, Esumi H, Hirano A, Kato M, Asayama K, Ohama E. Immunohistochemical expression of inducible nitric oxide synthase(iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase(SOD) proteins(SOD1 and SOD2), Ki-67 antigen(MIB-1) and p53 protein. Acta Neuropathol 2003;105(4):333-40.
  10. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37. https://doi.org/10.7326/0003-4819-120-3-199402010-00009
  11. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci 1995;92:7162-6. https://doi.org/10.1073/pnas.92.16.7162
  12. Mukhopadhyay P, Rajesh M, Batkai S, Kashiwaya Y, Hasko G, Liaudet L, et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin -induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009;296:466-83.
  13. Enukidze MG, Machavariani MG, Intskirveli NA, Bezhitashvili ND, Sanikidze TV. Cell death in Jurkat cells induced by oxygen/nitrogen stress. Georgian Med News 2009;167:109-13.
  14. Singh S, Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol 2011;67:1211-24. https://doi.org/10.1007/s00280-011-1654-4
  15. Pratheeshkumar P, Kuttan G. Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9. Eur J Pharmacol 2011;668:450-8. https://doi.org/10.1016/j.ejphar.2011.07.029
  16. Kostourou V, Cartwright JE, Johnstone AP, Boult JK, Cullis ER, Whitley G, et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. Br J Cancer 2011;104:83-90. https://doi.org/10.1038/sj.bjc.6606034
  17. Lin WL, Liang WH, Lee YJ, Chuang SK, Tseng TH. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells. Chem Biol Interact 2010;188:607-15. https://doi.org/10.1016/j.cbi.2010.09.002
  18. Liu SG, Wang BS, Jiang YY, Zhang TT, Shi ZZ, Yang Y, et al. Atypical protein kinase Ci (PKCi) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCi-SKP2-AKT pathway. Mol Cancer Res 2011;9:390-402. https://doi.org/10.1158/1541-7786.MCR-10-0359
  19. Wang J, Wu J, Hong J, Chen R, Xu K, Niu W, et al. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin ${\alpha}v{\beta}6$. Cancer Lett 2011;311:38-47. https://doi.org/10.1016/j.canlet.2011.06.025
  20. Hu JG, Wang XF, Zhou JS, Wang FC., Li XW, Lu HZ. Activation of PKC-alpha is required for migration of C6 glioma cells. Acta Neurobiol Exp 2010;70:239-45.
  21. Lee KG, Cho HJ, Bae YS, Park KK, Choe JY, Chung IK, et al. Bee venom suppresses LPS -mediated NO/iNOS induction through inhibition of PKC-alpha expression. J Ethnopharmacol 2009;123:15-21. https://doi.org/10.1016/j.jep.2009.02.044
  22. Lin TH, Kuo HC, Chou FP, Lu FJ. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008;8:58. https://doi.org/10.1186/1471-2407-8-58
  23. Wen J, Ribeiro R, Zhang Y. Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells. J Neuroinflammation 2011;8:38. https://doi.org/10.1186/1742-2094-8-38
  24. Lee YN. New Flora of Korea. Seoul: Kyo-Hak Publishing Co., Ltd.; 2006, p. 261.
  25. Heo J. Dong-eui-bo-gam. Seoul: Bupin Publishing Co., Ltd.; 2007, p. 2010.
  26. The Herbal medicine compilation committee of Oriental medicine college. Herbal medicine. Seoul: Younglim Publishing; 2006, p. 331-3.
  27. Dae SM. Hang-am-joong-cho-yak. Taipei: Kyeup- seogook-youhan-gongsa; 1983, p. 222-4.
  28. State Administration of Traditional Chinesemedicine. Joong-hwa-bon-cho. Shanghai: Sang-hae science technique Publishing; 2005, p. 605-10.
  29. Choi OB. The importance of clinical mistletoe cancer therapy and koreanmistletoe pharmacopuncture preparation development and application possibility for oriental medicine. J ofKorean Pharmacopuncture Institute 2009;12(1):77-89.
  30. Kim MJ, Lee MS, Kim JH. Effect of Korean mistletoe extract and lectin on the preneoplastic hepatic lesion and apoptosis in experimental hepatocarcinogenesis. J of Korean Society Food Science and Nutrition 2002;31(5):782-7. https://doi.org/10.3746/jkfn.2002.31.5.782
  31. Kim SU, Kim BR, Heo K, Lim SW. Comparative Study of KoreanMisltetoe Lectin and Bee Venom on the Anti-Cancer Effect and Its Mechanisms of Action in Hepatocellular Carcinoma Cells. Korean J Orient Int Med 2009;30(4):845-57.
  32. Rhew KY, Kim YC, Lee JH, Woo HJ. The Effects of Loranthus parasiticus Merr. on Cell Cycle and Expression of Related Genes in HepG2 Cell. Korean J Orient Int Med 2005;26(1):60-73.
  33. Kim JK, Kim YC, Lee JH, Woo HJ. The Effects of Artermisiae Capillaris Herba, Curcumae Rhizoma, Loranthi Ramulus, and Orostachys Herba on Expression of Angiogenic Factors in HepG2 Cells. Korean J Orient Int Med 2007;28(1):149-65.
  34. Yang EY, Yeo JH, Jin JY, Kim HS, Park WB, Suh JJ, et al. Anti-tumor effect of Korean mistletoe extract intensified with mistletoe lectin against melanoma cells in vitro and in vivo. Korean J of Pharmacognosy 2003;34(3):218-22.
  35. Yoon TJ, Park SM, Yang SH, Jung HY, Lee AN, Yoo YC, et al. In Vivo toxicity and anti-tumor activity of Korean mistletoe extracts. Korean J of Pharmacognosy 2009;40(3):205-12.
  36. Korea Food & Drug Administration. Korean Herbal medicine Standards exclusive of Pharmacopoeia. Seoul: Shinilbooks Publishing; 2007, p. 46.
  37. Uisung-Dang editorial department. Shin-nong -bon-cho-kyeong. Seoul: Uisung-Dang Publishing; 2012, p. 210.
  38. Kim BK, Choi MJ, Park KY, Cho EJ. Protective effects of Korean mistletoe lectin on radical-induced oxidative stress. Biological and Pharmaceutical Bulletin 2010;33(7):1152-8. https://doi.org/10.1248/bpb.33.1152
  39. Lee SJ, Lee MK, Choi GP, Kim NY, Roh SK, Heo MY, et al. Inhibitory effect of Korean mistletoes on the oxidative DNA damage. Korean J of Medicinal Crop Science 2003;11(2):89-96.
  40. Ham SS, Kang ST, Choi KP, Park WB, Lee DS. Antimutagenic effect of Korean mistletoe extracts. J of Korean Society Food Science and Nutrition 1998;27(2):359-65.
  41. Lee CH, Kim JK, Kim HY, Park SM, Lee SM. Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo. International Immunopharmacology 2009;9:1555-61. https://doi.org/10.1016/j.intimp.2009.09.011
  42. Lee JH, Cho SO, Ban JY, Song KS, Seong YH. Neuroprotective effect of Korean mistletoe extract against damage induced by hydrogen peroxide in cultured rat cortical neurons. Korean J of medicinal crop science 2007;15(2):105-11.
  43. Kim HS. Effects of the Korean mistletoe hot-water extract on the lipid components and blood pressure level in spontaneously hypertensive rats. Korean J of Pharmacognosy 2006;37(3):169-76.
  44. Seo JH, Choi YH, Kim JS, Kim SK, Choi SU, Kim YS, et al. Active principles of the methanol extract of Korean mistletoe responsible for the inhibitory effect on the proliferation of human tumor cell lines. Korean J of Pharmacognosy 2004;35(2):134-8.
  45. Yoon TJ, Yoo YC, Kang TB, Lee KH, Kwak JH, Baek YJ, et al. Fermented extracts of Korean mistletoe with lactobacillus(FKM-110) stimulate macrophage and inhibit tumor metastasis. Korean J of Food Science and Technology 1999;31(3):838-47.
  46. Choi SH, Lyu SY, Park WB. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Ark. Archives of Pharmacal Reasearch 2004;27(1):68-76. https://doi.org/10.1007/BF02980049
  47. Park WB, Lyu SY, Kim JH, Choi SH, Chung HK, Ahn SH, et al. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biotherapy and Radiopharmaceuticals 2001;16:439-47. https://doi.org/10.1089/108497801753354348
  48. Muntane J, la Mata MD. Nitric oxide and cancer. World J Hepatol 2010;2(9):337-44. https://doi.org/10.4254/wjh.v2.i9.337